3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
3.7739 1.2573 0.0013 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6900 1.8654 -0.0103 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7656 -1.8980 -0.0017 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.5914 -0.2432 0.0032 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2320 0.2956 0.0013 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3274 -1.1118 -0.0010 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0462 0.8702 0.0030 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3941 1.0857 0.0021 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1743 0.0626 0.0023 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6515 0.4889 0.0005 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5975 -1.6820 -0.0025 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7530 -0.8968 -0.0018 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9808 -1.3039 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5092 0.6338 0.0041 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0281 0.5763 -0.0004 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1462 1.9540 0.0052 H 0 0 0 0 0 0 0 0 0 0 0 0
1.3197 2.1714 0.0040 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7027 -2.7656 -0.0043 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6954 -1.4339 -0.0031 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7837 -2.0303 -0.0015 H 0 0 0 0 0 0 0 0 0 0 0 0
5.8115 1.3412 0.0005 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1617 -0.0179 -0.9109 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1626 -0.0209 0.9079 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5296 -1.2535 0.0097 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.5359 0.1292 -0.0024 H 0 0 0 0 0 0 0 0 0 0 0 0
1 10 1 0 0 0 0
1 15 1 0 0 0 0
2 14 2 0 0 0 0
3 6 2 0 0 0 0
3 13 1 0 0 0 0
4 14 1 0 0 0 0
4 24 1 0 0 0 0
4 25 1 0 0 0 0
5 6 1 0 0 0 0
5 7 2 0 0 0 0
5 8 1 0 0 0 0
6 11 1 0 0 0 0
7 9 1 0 0 0 0
7 16 1 0 0 0 0
8 10 2 0 0 0 0
8 17 1 0 0 0 0
9 13 2 0 0 0 0
9 14 1 0 0 0 0
10 12 1 0 0 0 0
11 12 2 0 0 0 0
11 18 1 0 0 0 0
12 19 1 0 0 0 0
13 20 1 0 0 0 0
15 21 1 0 0 0 0
15 22 1 0 0 0 0
15 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
6-methoxyquinoline-3-carboxamide
4.2 InChl
InChI=1S/C11H10N2O2/c1-15-9-2-3-10-7(5-9)4-8(6-13-10)11(12)14/h2-6H,1H3,(H2,12,14)
4.3 InChlKey
NLVPUORRLFNMCP-UHFFFAOYSA-N
4.4 Canonical SMILES
COC1=CC2=CC(=CN=C2C=C1)C(=O)N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病